Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
Authors
Keywords
-
Journal
Life-Basel
Volume 12, Issue 8, Pages 1141
Publisher
MDPI AG
Online
2022-07-29
DOI
10.3390/life12081141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic roles of KL‐6 in disease severity and lung injury in COVID‐19 patients: A longitudinal retrospective analysis
- (2021) Kai Deng et al. JOURNAL OF MEDICAL VIROLOGY
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup
- (2021) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
- (2021) Riccardo Scotto et al. International Journal of Environmental Research and Public Health
- The role of mucin 1 in respiratory diseases
- (2021) Beatriz Ballester et al. European Respiratory Review
- Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks
- (2021) David T. Arnold et al. PLoS One
- A systematic review and meta-analysis of obesity and COVID-19 outcomes
- (2021) Xinya Zhang et al. Scientific Reports
- Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019
- (2021) Ding-Hui Peng et al. CLINICA CHIMICA ACTA
- SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
- (2021) Filippo Scialo et al. Biomedicines
- Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
- (2021) Takafumi Yamaya et al. Respiratory Investigation
- Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study
- (2021) Lovisa Sjögren et al. PLoS One
- Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses
- (2021) Nadereh Naderi et al. VIROLOGY
- CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
- (2020) Michael Chung et al. RADIOLOGY
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
- (2020) Waleed Alhazzani et al. INTENSIVE CARE MEDICINE
- Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS
- (2020) Auguste Dargent et al. PLoS One
- Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
- (2020) Fabio Perrotta et al. RESPIRATORY MEDICINE
- Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
- (2020) Artur Słomka et al. Pathogens
- Peripheral biomarkers' panel for severe COVID‐19 patients
- (2020) Miriana d'Alessandro et al. JOURNAL OF MEDICAL VIROLOGY
- Anticoagulant treatment in COVID-19: a narrative review
- (2020) Vincenzo Carfora et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
- (2020) Ersilia Nigro et al. International Journal of Endocrinology
- Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study
- (2016) Ekin Oktay Oguz et al. CLINICAL RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More